Drug Makers, Benefit Managers Hit With Class Suit Alleging Insulin Pricing Scheme
NEWARK, N.J. — Three drug makers and the three largest pharmacy benefit managers have engaged in a pricing scheme to drive up the cost of diabetes insulin — by more than...To view the full article, register now.
Already a subscriber? Click here to view full article